African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2'-O-ribose methyltransferase: An in silico perspective
- PMID: 35431328
- PMCID: PMC9002684
- DOI: 10.1016/j.molstruc.2022.133019
African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2'-O-ribose methyltransferase: An in silico perspective
Abstract
Despite the ongoing vaccination against the life-threatening COVID-19, there is need for viable therapeutic interventions. The S-adenosyl-l-Methionine (SAM) dependent 2-O'-ribose methyltransferase (2'-O-MTase) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a therapeutic target against COVID-19 infection. In a bid to profile bioactive principles from natural sources, a custom-made library of 226 phytochemicals from African medicinal plants with especially anti-malarial activity was screened for direct interactions with SARS-CoV-2 2'-O-MTase (S2RMT) using molecular docking and molecular dynamics (MD) simulations as well as binding free energies methods. Based on minimal binding energy lower than sinefungin (a reference methyl-transferase inhibitor) and binding mode analysis at the catalytic site of S2RMT, a list of 26 hit phytocompounds was defined. The interaction of these phytocompounds was compared with the 2'-O-MTase of SARS-CoV and MERS-CoV. Among these compounds, the lead phytocompounds (LPs) viz: mulberrofuran F, 24-methylene cycloartenol, ferulate, 3-benzoylhosloppone and 10-hydroxyusambarensine interacted strongly with the conserved KDKE tetrad within the substrate binding pocket of the 2'-O-MTase of the coronavirus strains which is critical for substrate binding. The thermodynamic parameters analyzed from the MD simulation trajectories of the LPs-S2RMT complexes presented an eminent structural stability and compactness. These LPs demonstrated favorable druggability and in silico ADMET properties over a diverse array of molecular computing descriptors. The LPs show promising prospects in the disruption of S2RMT capping machinery in silico. However, these LPs should be validated via in vitro and in vivo experimental models.
Keywords: 2-O’-ribosemethyltransferase; Coronavirus; Molecular docking; Molecular dynamics; Mulberrofuran F; Phytochemicals; SARS-CoV-2.
© 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
















Similar articles
-
Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approach.J Biomol Struct Dyn. 2023 Jul;41(11):5022-5044. doi: 10.1080/07391102.2022.2078408. Epub 2022 May 28. J Biomol Struct Dyn. 2023. PMID: 35635123
-
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum.Comput Biol Med. 2021 Sep;136:104671. doi: 10.1016/j.compbiomed.2021.104671. Epub 2021 Jul 21. Comput Biol Med. 2021. PMID: 34332348 Free PMC article.
-
Binding of the Methyl Donor S-Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus 2'-O-Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10.J Virol. 2017 Feb 14;91(5):e02217-16. doi: 10.1128/JVI.02217-16. Print 2017 Mar 1. J Virol. 2017. PMID: 28031370 Free PMC article.
-
Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.J Biomol Struct Dyn. 2022 Feb;40(3):1331-1346. doi: 10.1080/07391102.2020.1828172. Epub 2020 Oct 4. J Biomol Struct Dyn. 2022. PMID: 33016237 Free PMC article.
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
Cited by
-
Machine learning-based QSAR and molecular modeling identify promising PTP1B modulators from Ocimum gratissimum for type 2 diabetes therapy.Mol Divers. 2025 Jun 23. doi: 10.1007/s11030-025-11255-x. Online ahead of print. Mol Divers. 2025. PMID: 40549293
-
Analysis of AlphaFold and molecular dynamics structure predictions of mutations in serpins.PLoS One. 2024 Jul 5;19(7):e0304451. doi: 10.1371/journal.pone.0304451. eCollection 2024. PLoS One. 2024. PMID: 38968282 Free PMC article.
-
Exploring beetroot (Beta vulgaris L.) for diabetes mellitus and Alzheimer's disease dual therapy: in vitro and computational studies.RSC Adv. 2024 Jun 17;14(27):19362-19380. doi: 10.1039/d4ra03638g. eCollection 2024 Jun 12. RSC Adv. 2024. PMID: 38887650 Free PMC article.
-
Molecular modeling of the interactions of compounds of Irvinga wombulu against dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum towards development of anti-malarial drug.In Silico Pharmacol. 2025 Feb 19;13(1):31. doi: 10.1007/s40203-025-00317-5. eCollection 2025. In Silico Pharmacol. 2025. PMID: 39990732
-
Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth.Front Mol Biosci. 2022 Aug 10;9:866719. doi: 10.3389/fmolb.2022.866719. eCollection 2022. Front Mol Biosci. 2022. PMID: 36032689 Free PMC article.
References
-
- World Health Organization . World Health Organization; 2021. Coronavirus Disease (COVID-19) Weekly Epidemiological. https://www.who.int/publications/m/item/weekly-epidemiological-update-on....
-
- Zhou P., YANG X., wANG X., HU B., w Z.H.A.N.G., Hr Si, y zHu, li B., cl HuanG, cHen H.D., cHen J., luo y, Guo H., rD JianG, liu M.Q., y cHen, Xr SHen, WanG X., zHenG X.S., zHao K., cHen Q.J., DenG F., ll liu, yan B., zHan F.X., yy WanG, Xiao G.F., zl SHi. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous